P/E ratio for Penumbra (PEN)
P/E ratio as of May 2024 (TTM): 275
According to Penumbra's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 274.747. At the end of 2022 the company had a P/E ratio of < -1000.
P/E ratio history for Penumbra from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | < -1000 | -300.58% |
| 2021 | > 1000 | -581.6% |
| 2020 | -398 | -438.97% |
| 2019 | 117 | -81.76% |
| 2018 | 643 | -11.15% |
| 2017 | 724 | 455.93% |
| 2016 | 130 | -77.74% |
| 2015 | 585 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | 44.3 | -83.89% | 🇺🇸 USA |
 Inari Medical
NARI | -840 | -405.66% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.